Terns Pharmaceuticals
TERN
TERN
155 hedge funds and large institutions have $663M invested in Terns Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 53 increasing their positions, 37 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
155
Holders Change
+29
Holders Change %
+23.02%
% of All Funds
2.24%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
52
Increased
53
Reduced
37
Closed
23
Calls
$8.73M
Puts
$4.45M
Net Calls
+$4.28M
Net Calls Change
+$1.38M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$18.5M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$17.8M |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
+$13.7M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$12.1M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$10.6M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$13.3M |
| 2 |
OCA
Octagon Capital Advisors
New York
|
-$9.29M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$7.83M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$7.65M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$6.64M |
